Jacob Ballas makes modest returns from Vivimed Labs’ part-exit

Mid-market private equity firm Jacob Ballas Capital has marked its third liquidity event this year as it looks to harvest its investments from its last India-focused funds raised almost a decade ago.The firm has part-exited active pharmaceutical ingredients (API) and chemicals maker Vivimed Labs Ltd last week, its second such ......